ANNPO Biotechnology Inc. was founded in 2010 by Cantonese entrepreneurs and American biopharmaceutical specialists. The company is located in the heart of the Chinese Academy of Sciences Foshan (CAS-FS) Biotech and Pharmaceutical Centre, a professional biomedical and pharmaceutical industry park, complete with a charming lakeside view. The company has established advanced level technology platforms and state-of-the-art equipment and facilities for the development of biological drugs.

       ANNPO Bio is an up and coming biopharma R&D company. The senior members of our management and technical team have many years of experience in major biopharmaceutical companies in both US and China, with extensive knowledge and understanding of the development and commercialization of biological drugs. We are committed to introducing world class bio-manufacturing and quality assurance into China and becoming a mainstream player in the bio-pharmaceutical area. Our commitment to bring our biologic drugs to the market in China has us striving for continuous enhancement of our technical expertise and international competitiveness.

       ANNPO Bio has more than fifty million RMB invested in multiple drug projects at various stages of development. A 2000-square meter R&D lab and a 500L-scale pilot plant were recently constructed and became operational in 2015. The pilot facility is operated in compliance with cGMP regulations of both the Chinese CFDA and European EMEA.